tradingkey.logo
搜索

Evotec SE

EVO
添加自选
1.530USD
-0.010-0.65%
收盘 09-24 16:00(美东)
543.75M总市值
亏损市盈率 TTM

关于 Evotec SE 公司

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SE 简介

公司代码EVO
公司名称Evotec SE
上市日期Oct 11, 1999
CEOWojczewski (Christian)
员工数量4827
证券类型Depository Receipt
年结日Oct 11
公司地址Essener Bogen 7
城市HAMBURG
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Germany
邮编22419
电话4940560810
网址https://www.evotec.com/
公司代码EVO
上市日期Oct 11, 1999
CEOWojczewski (Christian)

Evotec SE公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Ashiq H. Khan
Dr. Ashiq H. Khan
Chief Commercial Officer, Member of the Management Board
Chief Commercial Officer, Member of the Management Board
--
--
Mr. Dieter Weinand
Mr. Dieter Weinand
Chairwoman of the Supervisory Board
Chairwoman of the Supervisory Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--

常见问题

Evotec SE的前五大股东是谁?

Evotec SE 的前五大股东如下:Dr. Cord Dohrmann, Ph.D.

有多少机构持有Evotec SE(EVO)的股份?

截至2026Q1,共有81家机构持有Evotec SE的股份,合计持有的股份价值约为9.58M,占公司总股份的2.69%。与2025Q4相比,机构持股有所增加,增幅为-584606.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有